Financhill
Back

Neurogene Stock Predictions

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 47.1% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $49.43. The Score for NGNE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 47.1% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
50
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
53.00
52-Week Low:
12.49

Prediction Charts

Market Cap:
642.27M
Price in USD:
49.43
Volume:
170.98K
Beta:
-1.27

Technical Analysis

SMA50:
39.14
SMA100:
38.49
SMA200:
36.07
52-Wk Change:
215.24%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 49.43 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-24 40.10 40.83 42.29 39.41
Sep-25 41.02 41.93 44.75 40.75
Sep-26 42.40 39.42 43.78 38.56
Sep-27 39.87 40.33 41.45 39.86
Sep-30 40.23 41.96 43.05 39.25
Oct-1 41.68 39.94 41.68 38.35
Oct-2 39.48 41.75 42.00 38.14
Oct-3 41.55 44.68 44.68 41.40
Oct-4 44.89 48.59 51.30 44.37
Oct-7 48.40 47.60 48.92 46.32
Oct-8 47.60 50.34 50.59 47.53
Oct-9 50.32 49.55 51.42 48.41
Oct-10 48.73 48.15 50.29 47.87
Oct-11 48.15 49.43 50.13 47.81

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.